// Biotech and Pharma Therapeutics Bayer Receives U.S. FDA Fast Track Designation for asundexian Atrial Fibrillation Program May 16, 2023 / Bayer / FDA / Fibrilation Program Bayer today announced that the U.S. Food and Drug Administration (FDA) has granted...